Effect of a Probiotic on Microbiota Associated with the Immune System and Inflammation.

NCT ID: NCT06313346 Phase: NA Status: COMPLETED Enrollment: 60 Completion: 2024-06-15

Conditions

Probiotic, Microbiota

Interventions

Probiotic, Placebo

Summary

The goal of this randomized clinical trial is to learn about the effect of consuming a probiotic on the microbiota associated with immune health and inflammation in healthy women and men after 6 weeks of intervention.

The main questions to answer are:

  1. To study changes in the intestinal microbiota associated with immune health and inflammation related to probiotic intake.
  2. To evaluate changes in salivary cortisol after ingestion of the probiotic.
  3. To compile the number and intensity of catarrhal episodes suffered by the participants along the study.

For this purpose, a randomized, double blind parallel study has been designed.

Target sample size is 60 subjects.

Participants will be allocated in two groups for 6 weeks:

  • Experimental group (n=30): daily consumption of one probiotic capsule.
  • Placebo group (n=30): daily consumption of one placebo capsule.

Primary Outcome

Fecal microbiota

Source

ClinicalTrials.gov